Five-Year Results Confirm Efficacy of HEMGENIX in Hemophilia B
A recent study published in the New England Journal of Medicine reveals that HEMGENIX (etranacogene dezaparvovec-drlb) demonstrates long-term durability and safety over a five-year period in adults with hemophilia B.…